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Abstract
Background: Acupuncture is often used to treat fibromyalgia (FM), but it remains unclear whether acupuncture is
effective. This study aims to evaluate the effects of acupuncture on pain and quality of life (QoL) in FM patients.
Methods: Sixteen patients (13 women and 3 men aged 25-63 years) suffering from FM were randomised into two
groups: group A (n = 8) received five acupuncture treatments after the fifth week and group B received ten
acupuncture treatments. Outcome measures used in this study were pain intensity (visual analogue scale, VAS) and
the fibromyalgia impact questionnaire (FIQ).
Results: After the fifth week, pain intensity (U = 25.0; P = 0.022) in group B decreased and QoL (U = 24.5;
P = 0.026) improved compared to group A.
Conclusion: The present study suggests that acupuncture treatment is effective to relieve pain for FM patients in
terms of QoL and FIQ.
Background
Fibromyalgia (FM) is a condition of unknown cause; it is
characterized by widespread musculoskeltal pain with
symptoms including stiffness, fatigue, sleep disturbance
and functional impairment [1,2]. According to the
American College of Rheumatology criteria, an FM
patient must have chronic widespread pain and at lest
11 out of 18 tender points on examination [1]. Affecting
2-4% of the populations in industrialized countries, FM
is the second most common rheumatologic disorder in
the world [3,4]. A wide range of treatment methods are
currently in use such as medications, physical methods
and manual treatments [5,6]. Complementary and alter-
native medicine (CAM) is commonly used to treat FM
patients [7]. Ninety-one per cent (91%) FM patients
used CAM [8] and significantly more FM patients used
CAM compared to patients of other rheumatologic dis-
eases [9]. One of the most commonly used forms of
CAM is acupuncture (annual utilization percentages,
from 4.8-6.7% of lifetime experiences to 19.4-26.7% in
Japan) [10]. Although acupuncture has been used for
pain relief for a long time in China and around the
world, studies on the efficacy of acupuncture on FM
provided mixed results [1,11]. Most studies which indi-
cated beneficial effect of acupuncture treatment for FM
were uncontrolled case series [1,11,12]; only a few sup-
ported that acupuncture was effective [1,13-16]. A
recent systematic review found no evidence to show
beneficial effects of acupuncture to treat FM compared
with placebo [1]. Although efficacy of acupuncture have
been assessed with various controls such as no-treat-
ment controls [17], non-penetration needling [18], mini-
mal acupuncture [19,20] and mock transcutaneous
electrical nerve stimulation (TENS) [21,22], most studies
on the efficacy of acupuncture for FM were uncon-
trolled case series that utilized electroacupuncture treat-
ment [1,11], which make the setting of controls difficult
because it involves perceptible current [23]. One of the
alternative ideas which enable evaluation of the efficacy
of acupuncture acceptable may be utilization of standard
medication as a control condition. The present study
aims to determine the efficacy of acupuncture in the
symptomatic treatment for FM in comparison to the
commonly-used medications.
Methods
Patients
Participants in the present study were 16 patients who
were diagnosed with FM by specialists in respective
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Center, Meiji University of Integrative Medicine (Kyoto,
Japan), seeking ways in relieving symptoms. Inclusion
criteria were: (1) having met the American College of
Rheumatology criteria for the diagnosis of FM for at
least one year; (2) widespread pain for six months or
more; (3) normal neurological examination findings of
nerve function, including deep tendon reflexes, volun-
tary muscle action and sensory function; and (4) failure
to respond to medications prescribed by FM specialists.
Exclusion criteria were: (1) sufficient knowledge of acu-
puncture which may prevent blinding (e.g. having
received acupuncture previously); (2) known bleeding
diathesis; (3) having autoimmune or inflammatory dis-
eases; (4) participation in other clinical trials; (5) preg-
nancy or lactation; or (6) receiving disability payments
or involved in litigation related to FM. However,
patients receiving FM medications were included if
there had been no change in their medications for one
month or longer prior to recruitment.
Patients having signed a written informed consent
were recruited and randomly assigned with a compu-
terised randomisation program (SAMPSIZE V2.0, Black-
well Sience Ltd, UK, permutated block randomization)
to either group A where patients received acupuncture
treatment followed by a control period or group B
where they received continuous acupuncture. This study
was approved by the Ethics Committee of Meiji Univer-
sity of Integrative Medicine.
The two groups received a total of five (group A) or
ten (group B) acupuncture treatments once a week.
Each session lasted for 30 minutes. Group A (control)
received a total of five acupuncture treatments after
the control period of five weeks. Patients in group A
received clinical examinations once or twice a week for
over five weeks by a FM specialist prior to the inter-
vention period whereas those in group B received a
total of 10 acupuncture treatments (Figure 1).
Blinding
Outcome measures were performed by an independent
investigator who was not informed of the treatment
sequence or the treatment the patient had received prior
to each measurement.
Intervention
Electroacupuncture and trigger point acupuncture were
used to treat the patients. Patients received 15 minutes
of electroacupuncture and then 15 minutes of trigger
point acupuncture. Four pairs of electrodes were placed
on the forearms and lower legs of the patients who
were connected to a pulse generator (OhuPulser LFP-
4000A, Zen Lryoki Corp, Japan). The current was rec-
tangular with a biphasic top and a frequency of 4 Hz.
Intensity of the current was set between the perception
and pain thresholds inducing a visible muscular con-
traction. Disposable stainless steel needles (0.2 mm ×
40 mm, Seirin, Japan) were inserted into the skin over
the point to a depth of 5-20 mm. Depth of insertion
was determined according to the patient’s needling
sensation of the specific site. Both sides of four com-
mon acupuncture points were used for patients receiv-
ing electroacupuncture.
Up to ten additional sites were chosen according to
the patient’ss y m p t o m sa n dp a i np a t t e r na sw e l la st h e
empirical choice of trigger point in pain treatment. Dis-
posable stainless steel needle (0.2 mm × 40 mm, Seirin,
Japan) was inserted into the skin over the trigger point
to a depth of 10-20 mm, appropriate to the muscle
(Table 1), attempting to elicit a local muscle twitch
Figure 1 Treatments and measurements in this trial.
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the local twitch response or a reasonable attempt, the
needle was retained for ten more minutes.
The acupuncture was performed by an acupuncturist
who had four years of acupuncture training and clinical
experience of three or ten years.
Evaluation
Primary outcome measures included pain intensity
quantified with a 10 cm visual analogue scale (VAS) and
pain disability measured with the fibromyalgia impact
questionnaire (FIQ) [24] on physical function, work,
wellbeing. FIQ includes VAS for pain, sleep, fatigue,
stiffness, anxiety and depression. Total score ranges
between 0-100 with a higher score indicating a negative
impact.
The VAS and FIQ measures were completed by the
patients immediately before each treatment and analysed
immediately before the first treatment (pre), five and ten
weeks after the first treatment.
Statistical analysis
Outcome measures are reported as medians and inter-
quartile ranges. Mann-Whitney U test was used to
analyse differences between groups at each time per-
iod. A difference was considered statistically significant
when the P value was less than 0.05. The success of
blinding was analysed by Fisher’s exact test. Statistical
package SYSTAT 12 (SYSTAT Software Inc, USA) was
used to perform all the statistical analyses in this
study.
Results
Patient characteristics
Sixteen participants (13 women and 3 men aged 25-
63 years) were randomised (Figure 2). No statistically
significant differences in terms of age, pain duration,
VAS and treatments received were found between the
two groups at baseline (Table 2).
Table 1 Muscles treated in the two trigger point
acupuncture groups
Muscle Group A Group B
Sternocleidomastoideus 5* 5
Trapezius 65
Pectoralis major 55
Quadratus lumborum 44
Erector spinae 65
Gluteus medius 54
Hamstrings 43
Other 54
*number of the patients of which the indicated muscle was stimulated with
the acupuncture needle (summation of these numbers is not equal to the
total number of the participants because of duplicated counting)
Analysed (n=7)
Excluded from analysis (n=1)
Assessed for eligibility
(n=16)
Allocated to group A
(n=8)
Received intervention (n=8)
Did not receive intervention (n=0)
Allocated to group B
(n=8)
Received intervention (n=8)
Did not receive intervention (n=0)
Lost to follow-up (n=2)
Discontinued intervention (n=2)
Lost to follow-up (n=1)
Discontinued intervention (n=1)
Analysed (n=6)
Excluded from analysis (n=2)
Randomised (n=16)
Excluded (n=0)
Enrolment
Allocation
Treatment
Analysis
Figure 2 Participants flow in the study.
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dropped out due to a lack of response to treatments.
The dropout rates were not significantly different
between the groups (P = 0.52, Fisher’s exact test). Ana-
lyses were performed on the 13 patients who did com-
plete the study.
VAS scores
While the median VAS score in group A remained
unchanged, those in group B decreased by the fifth
week of treatment (Figure 3). However, the VAS score
in group A began to decrease after the fifth week when
the patients in this group also started receiving acu-
puncture treatment. There was a significant difference
in the VAS scores between groups A and B at the fifth
week (U = 25.0, P = 0.022), whereas there was no signif-
icant difference between the groups at baseline (U = 5.0,
P = 0.566) and at the tenth week (U =1 3 . 0 ,P =0 . 2 5 2 )
(Figure 3 and Table 3).
QoL impairment
While the FIQ score decreased after acupuncture treat-
ments in group B for five weeks, those in group B
remained unchanged. However, FIQ scores in both
groups A and B decreased after the fifth week when
patients in both groups received acupuncture. There
was a significant difference between groups at the fifth
Table 2 Characteristics of patients in the three groups
Group A Group B
Sample size 76
Age 45.7 (15.2) 47.3 (13.3)
Pain duration (y) 3.9 (3.9) 4.4 (2.3)
VAS (mm) 74.2 (8.4) 77.9 (10.1)
FIQ 64.3 (6.4) 66.3 (11.0)
Treatments received:
Amitriptylin 44
SSRIs 23
SNRIs 21
Data are expressed as mean (standard deviation)
Figure 3 Effects of acupuncture on VAS score. There was a significant difference between group A and B (U = 25.0, P = 0.022), while no
significant difference between groups at baseline (U = 5.0, P = 0.566) and tenth week (U = 13.0, P = 0.252).
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f e r e n c eb e t w e e nt h eg r o u p sa tb a s e l i n e( U =5 . 5 ,
P = 0.616) and at the tenth week (U =9 . 0 ,P =0 . 0 8 6 )
(Figure 4 and Table 4).
Discussion
The present study demonstrated a statistically signifi-
cant difference between the acupuncture and active
control (standard medication) groups five weeks after
the first treatment. Moreover, the additionally
performed acupuncture treatment after the fifth week
in the control group resulted in the further reduction
of the FM symptoms. These results suggest that acu-
puncture treatment is capable of giving additional
improvement to the standard medication in the treat-
ment of FM.
The importance of randomised controlled trials
(RCT) to study the placebo effect of acupuncture was
debated [25,26]. Acupuncture RCTs with various con-
trol methods such as no-treatment controls [17], non-
penetration needling [18], minimal acupuncture [19,20]
and mock transcutaneous electrical nerve stimulation
(TENS) [21,22] have been carried out. However, posi-
tive results were often obtained in studies with a non-
acupuncture control [26,27], whereas negative results
tended to be from those with sham acupuncture or
mock TENS [28,29].
Table 3 Pain intensity VAS scores
Week Group A Group B
Pre 75.5 (68.5-81.0) 77.8 (72.0-82.5)
5 73.5 (68.3-75.0) 47.4 (39.5-61.0)*
10 52.0 (43.0-53.0) 36.3 (24.0-50.5)
Data are medians (interquartile ranges). * P <0 . 0 5 .
Figure 4 Effects of acupuncture on FIQ score. There was a significant difference between group A and B at the fifth week (U = 24.5, P =
0.026), while no difference between at baseline (U = 5.5, P = 0.616) and tenth week (U = 9.0, P = 0.086).
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to treat FM were uncontrolled case series with electroa-
cupuncture treatment [1,11]. As electroacupuncture
involves perceptible current, sham acupuncture as con-
trol may not work for electroacupuncture. In fact, Tar-
gino et al. reported that addition of acupuncture to
usual treatment for FM was beneficial for pain and QoL
[16]. Our study also demonstrated that utilization of
standard treatment as a control may be an ideal method
to evaluate efficacy of acupuncture on FM. Although
there were three patients who could not complete the
study protocol, we consider the number had not much
impact on the results because the numbers of withdra-
wal were similar between groups (2 out of 8 in group A
and 1 out of 8 in group B). One of the limitations of the
present study is relatively small sample size. Larger scale
studies are required in the future.
Conclusion
The present study suggests that acupuncture treatment
is effective to relieve pain for FM patients in terms of
QoL and FIQ. Further larger scale clinical trials are war-
ranted to confirm the findings of this study.
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